​

Skye Bioscience Ownership | Who Owns Skye Bioscience?

OverviewForecastFinancialsChartTranscripts

Skye Bioscience Ownership Summary

Skye Bioscience is owned by 32.23% institutional investors, 1.44% insiders, and 66.33% retail investors. Vanguard personalized indexing management is the largest institutional shareholder, holding 0% of SKYE shares.

SKYE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSkye Bioscience32.23%1.44%66.33%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard personalized indexing management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vanguard personalized indexing management---

Top Buyers

HolderShares% AssetsChange
Vanguard personalized indexing management---13.33K

Top Sellers

HolderShares% AssetsChange
Vanguard personalized indexing management---13.33K

Sold Out

HolderChange
Vanguard personalized indexing management-13.33K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025742.78%12,779,599-49.30%320.68%29-29.27%19111.11%
Dec 31, 202472-4.00%25,208,445-2.03%691.57%41-9-10.00%
Sep 30, 20247517.19%25,730,0905.03%661.65%41-31.67%10-
Jun 30, 2024642033.33%24,496,7341119.17%63123.02%602900.00%--
Mar 31, 20243200.00%2,009,303125481.44%71378182.02%2100.00%--

Recent Insider Transactions

DateNameRoleActivityValue
Nov 18, 2024ARSENAULT KAITLYN Chief Financial OfficerSell$214.70K
Nov 15, 2024ARSENAULT KAITLYN Chief Financial OfficerSell$1.05K
Nov 15, 2024Diep Tuan Tu Chief Development OfficerSell$471.75
Nov 18, 2024Diep Tuan Tu Chief Development OfficerSell$97.25K
Nov 15, 2024ARSENAULT KAITLYN Chief Financial OfficerSell$1.05K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1--
2024 Q4-10
2024 Q3-12
2024 Q12-

SKYE Ownership FAQ

Who Owns Skye Bioscience?

Skye Bioscience shareholders are primarily institutional investors at 32.23%, followed by 1.44% insiders and 66.33% retail investors. The average institutional ownership in Skye Bioscience's industry, Biotech Stocks , is 64.05%, which Skye Bioscience falls below.

Does Blackrock own Skye Bioscience?

BlackRock is not among the top 10 institutional shareholders of Skye Bioscience.

Who is Skye Bioscience’s biggest shareholder by percentage of total assets invested?

Vanguard personalized indexing management is Skye Bioscience’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Skye Bioscience shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools